| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4001888 | American Journal of Ophthalmology | 2016 | 11 Pages |
Abstract
The Boston keratoprosthesis type 1 is an effective device for rehabilitation in advanced ocular surface disease, resulting in a significant improvement in visual acuity. Eyes achieved a mean value of 20/150 (0.89 ± 0.64 logMAR units) after 6 months and this was relatively stable thereafter. The best visual prognosis is observed in chemical injury eyes, whereas the worst prognosis is in aniridia, although the latter has limited visual potential.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Christopher J. Rudnisky, Michael W. Belin, Rong Guo, Joseph B. Ciolino,